Agios Pharmaceuticals | AGIO - EPS Earnings Per Share


Agios Pharmaceuticals reported $-1.69 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 -1.47 -1.78 Oct/29
FY2026Q2 Jun/2026 -1.69 -1.67 -1.93 Jul/30
FY2026Q1 Mar/2026 -1.69 -1.79 -1.55 Apr/29
FY2025Q4 Dec/2025 -1.86 -1.95 -1.44 Feb/12
FY2025Q3 Sep/2025 -1.78 -1.91 16.22 Oct/30




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Arrowhead Research USD -1.36 0.43 Jun/2026
Astellas Pharma JPY 24.29 31.75 Mar/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Daiichi Sankyo JPY 37.72 11.03 Jun/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Exelixis USD 0.87 0.1 Mar/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Moderna USD -1.97 1.43 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.77 0.02 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026